Sensus Healthcare (SRTS) Gains from Investment Securities (2017 - 2026)
Sensus Healthcare (SRTS) recorded quarterly Gains from Investment Securities of $1.7 million in Q1 2026, up 269.05% quarter-over-quarter from -$992000.0 in Q4 2025, and up 4758.26% on a YoY basis from $34518.0 in Q1 2025.
Sensus Healthcare (SRTS) Gains from Investment Securities (2017 - 2026) Analysis & Trends
Sensus Healthcare's Gains from Investment Securities history runs 10 years deep, the most recent figure standing at $1.7 million for Q1 2026.
- In Q1 2026, Gains from Investment Securities rose 4758.26% year-over-year to $1.7 million; the TTM figure through Mar 2026 stood at $1.7 million (up 10.47% YoY), while the FY2025 annual figure was $1.7 million, up 19550.71% from the prior year.
- Gains from Investment Securities was $1.7 million for Q1 2026 at Sensus Healthcare, up from -$992000.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $1.7 million in Q1 2026 to a low of -$992000.0 in Q4 2025.
- Historically, Gains from Investment Securities has averaged $331387.4 across 5 years, with a median of $246000.0 in 2023.
- The sharpest annual moves came in 2025 and 2026: Gains from Investment Securities sank 1018.52% in 2025, then jumped 4758.26% in 2026.
- A 5-year view of Gains from Investment Securities shows it stood at $1.1 million in 2022, then tumbled by 77.49% to $246000.0 in 2023, then slumped by 56.1% to $108000.0 in 2024, then tumbled by 1018.52% to -$992000.0 in 2025, then soared by 269.05% to $1.7 million in 2026.
- The last three Gains from Investment Securities figures came in at $1.7 million (Q1 2026), -$992000.0 (Q4 2025), and $200223.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn |
| 10 | Sensus Healthcare | 44.45 Mn | 26.12 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.68 Mn |
| Mar 31, 2026 | 1.68 Mn |
| Dec 31, 2025 | -992,000.00 |
| Dec 31, 2025 | -992,000.00 |
| Sep 30, 2025 | 200,223.00 |
| Sep 30, 2025 | 200,223.00 |
| Jun 30, 2025 | 200,223.00 |
| Jun 30, 2025 | 200,223.00 |
| Mar 31, 2025 | -36,000.00 |
| Mar 31, 2025 | -36,000.00 |
| Dec 31, 2024 | 108,000.00 |
| Dec 31, 2024 | 108,000.00 |
| Sep 30, 2024 | 295,223.00 |
| Sep 30, 2024 | 295,223.00 |
| Jun 30, 2024 | 295,223.00 |
| Jun 30, 2024 | 295,223.00 |
| Mar 31, 2024 | 294,473.00 |
| Mar 31, 2024 | 294,473.00 |
| Dec 31, 2023 | 246,000.00 |
| Dec 31, 2023 | 246,000.00 |